{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:44:03Z","timestamp":1791225843628,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"doctoral school of the \u201ciuliu ha\u0163ieganu\u201d university of medicine and pharmacy","award":["160\/51\/19.01.2018"],"award-info":[{"award-number":["160\/51\/19.01.2018"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>In this observational pilot study, we investigated the impact of Dolutegravir, Raltegravir, Elvitegravir (Integrase Strand Transfer Inhibitors, INSTIs), or boosted Darunavir (a Protease Inhibitor, PI) in combination with two nucleoside reverstranscriptase inhibitors (Emtricitabine\/Tenofovir disoproxil or Lamivudine\/Tenofovir disoproxil, NRTI) on four interleukins (IL-4, IL-10, IL-13, and IL-21) as immune activation markers in na\u00efve HIV(Human Immunodeficiency Virus)-infected patients during the first six months of combined standard-of-care antiretroviral therapy (cART). Newly diagnosed with HIV-infected subjects and without any disease that could affect the immune activation markers were evaluated. The patients\u2019 physicians recommended the cART as standard-of-care and the ILs were measured before cART and six months of cART. The levels of CD4<jats:sup>+<\/jats:sup> T-cells count and CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> ratio significantly increased at six months (P-value&lt;0.02) regardless of the drugs, INSTIs or PI. However, a CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> &gt;1 was observed in 25% of patients treated with Raltegravir and half of those treated with Dolutegravir. At six months of cART, viral load was detectable in only 6\/31 individuals. IL-21 had an undetectable level in 30\/31 patients after six months of cART. Our results suggest the potency in restoring immune markers in HIV-infected patients with all investigated drugs. Dolutegravir showed a tendency to statistically significant changes in IL-4 and IL-10. A clinical trial with random allocation of medication and an extensive follow-up is needed to replicate this research and validate the usefulness of evaluated ILs as markers of cART effectiveness.<\/jats:p>","DOI":"10.1371\/journal.pone.0260007","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T18:29:37Z","timestamp":1637087377000},"page":"e0260007","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of several serum interleukins as markers for treatment effectiveness in na\u00efve HIV infected patients: A pilot study"],"prefix":"10.1371","volume":"16","author":[{"given":"Cristian","family":"Jianu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Itu-Mure\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Drugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Filipescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Violeta","family":"Topan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela Elena","family":"Jianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Iulia","family":"Morar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-4311","authenticated-orcid":true,"given":"Sorana D.","family":"Bolboac\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"pone.0260007.ref001","unstructured":"World Health Organization. HIV\/AIDS. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids (Accessed on 5th October 2021)."},{"key":"pone.0260007.ref002","unstructured":"GLOBAL AIDS UPDATE | 2021. Confronting Inequalities. Lessons for pandemic responses from 40 years of AIDS. Available online: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2021-global-aids-update_en.pdf (Accessed on 5th October 2021)."},{"key":"pone.0260007.ref003","unstructured":"World Health Organization. HIV\/AIDS. Antiretroviral therapy. Available online: https:\/\/www.who.int\/hiv\/topics\/treatment\/en\/ (Accessed on 20th December 2020)."},{"key":"pone.0260007.ref004","unstructured":"Clinical Info HIV.gov. Available on-line: https:\/\/aidsinfo.nih.gov\/guidelines (Accessed on 20th December 2020)."},{"key":"pone.0260007.ref005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/imr.12064","article-title":"Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs","volume":"254","author":"EMP Wilson","year":"2013","journal-title":"Immunol Rev"},{"key":"pone.0260007.ref006","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort","volume":"2","author":"S Croxford","year":"2017","journal-title":"Lancet Public Health"},{"issue":"9","key":"pone.0260007.ref007","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrmicro2848","article-title":"Microbial translocation in HIV infection: causes, consequences and treatment opportunities","volume":"10","author":"NG Sandler","year":"2012","journal-title":"Nat Rev Micorbiol"},{"key":"pone.0260007.ref008","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"CV Fletcher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"pone.0260007.ref009","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.282.17.1627","article-title":"Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy","volume":"282","author":"G Dornadula","year":"1999","journal-title":"JAMA"},{"key":"pone.0260007.ref010","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1182\/blood-2012-12-470393","article-title":"Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy","volume":"122","author":"DE Ouedraogo","year":"2013","journal-title":"Blood"},{"key":"pone.0260007.ref011","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"LM McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"pone.0260007.ref012","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"INSIGHT SMART Study Group","year":"2008","journal-title":"PLoS Med"},{"key":"pone.0260007.ref013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"INSIGHT SMART Study Group","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0260007.ref014","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"J Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00002030-199208000-00004","article-title":"Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection","volume":"6","author":"L Kestens","year":"1992","journal-title":"AIDS"},{"key":"pone.0260007.ref016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it","volume":"265","author":"A Boasso","year":"2009","journal-title":"J Intern Med"},{"key":"pone.0260007.ref017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CVI.13.5.556-560.2006","article-title":"Lymphatic tissue fibrosis is associated with reduced numbers of na\u00efve CD4+ T cells in human immunodeficiency virus type 1 infection","volume":"13","author":"TW Schacker","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 1","key":"pone.0260007.ref018","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00002030-200304001-00008","article-title":"HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era","volume":"17","author":"M Moroni","year":"2003","journal-title":"AIDS"},{"key":"pone.0260007.ref019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/504718","article-title":"Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA","volume":"194","author":"M Goicoechea","year":"2006","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref020","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"PW Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref021","doi-asserted-by":"crossref","first-page":"ofy288","DOI":"10.1093\/ofid\/ofy288","article-title":"-FABP is higher in people with chronic HIV than elite controllers, related to sugar and fatty acid intake and inversely related to body fat in people with HIV","volume":"5","author":"LT Cheru","year":"2018","journal-title":"IOpen Forum Infect Dis."},{"key":"pone.0260007.ref022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2015.01.038","article-title":"History of interleukin-4","volume":"75","author":"WE Paul","year":"2015","journal-title":"Cytokine"},{"issue":"8","key":"pone.0260007.ref023","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"AR Stacey","year":"2009","journal-title":"J Virol"},{"key":"pone.0260007.ref024","first-page":"498","article-title":"HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control [published correction appears in J Immunol. 2010, 185(4), 2632\u20132633].","volume":"185","author":"FY Yue","year":"2010","journal-title":"J Immunol."},{"key":"pone.0260007.ref025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/QCO.0000000000000510","article-title":"Assessing inflammation and its role in co-morbidities among persons living with HIV","volume":"32","author":"TE Peterson","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"pone.0260007.ref026","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiv123","article-title":"Factors associated with plasma IL-6 levels during HIV infection","volume":"212","author":"\u00c1H Borges","year":"2015","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref027","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","article-title":"INSIGHT Study Group. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death","volume":"203","author":"DR Boulware","year":"2011","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0463.2006.apm_108.x","article-title":"IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy","volume":"114","author":"MA Orsilles","year":"2006","journal-title":"APMIS"},{"key":"pone.0260007.ref029","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1590\/S0037-86822012000600002","article-title":"Immunovirological parameters and cytokines in HIV infection","volume":"45","author":"KI Tasca","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"key":"pone.0260007.ref030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11904-017-0356-x","article-title":"Inflammation, Immune Activation, and Antiretroviral Therapy in HIV","volume":"14","author":"CO Hileman","year":"2017","journal-title":"Curr HIV\/AIDS Rep."},{"key":"pone.0260007.ref031","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/hiv.12421","article-title":"Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.","volume":"18","author":"S Teeraananchai","year":"2017","journal-title":"HIV Med"},{"key":"pone.0260007.ref032","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/civ327","article-title":"Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s","volume":"61","author":"T Kelesidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"pone.0260007.ref033","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"MD Ward","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"pone.0260007.ref034","unstructured":"HIV Infection and AIDS. Public Health Guidance on HIV, Hepatitis B and C Testing in the EU\/EEA. Available online: https:\/\/ecdc.europa.eu\/en\/publications-data\/public-health-guidance-hiv-hepatitis-b-and-c-testing-eueea (Accessed on 21st December 2020)."},{"key":"pone.0260007.ref035","unstructured":"Guideline for the management of people living with HIV (PLWH) in Europe. Available online: https:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html (Accessed on 12th April 2021)."},{"key":"pone.0260007.ref036","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/medicina55120765","article-title":"A view of human immunodeficiency virus infections in the north-west region of Romania","volume":"55","author":"C Jianu","year":"2019","journal-title":"Medicina (Kaunas)."},{"key":"pone.0260007.ref037","unstructured":"HIV\/AIDS Infection in Romania UPDATE 30 June 2020. Available online: http:\/\/cnlas.ro\/images\/doc\/30062020_eng.pdf (Accessed on 21st December 2020)."},{"key":"pone.0260007.ref038","unstructured":"HIV\/AIDS surveillance in Europe 2019. 2018 data European Center for Disease Prevention and Control. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HIV-annual-surveillance-report-2019.pdf (Accessed on 21st December 2020)."},{"key":"pone.0260007.ref039","unstructured":"EACS Guidelines version 10.1 October 2020. Available online: https:\/\/www.eacsociety.org\/files\/guidelines-10.1_5.pdf (Accessed on 21st December 2020)."},{"key":"pone.0260007.ref040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"NI Wada","year":"2015","journal-title":"AIDS"},{"key":"pone.0260007.ref041","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstruction of CD4+ T cells","volume":"200","author":"MA French","year":"2009","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref042","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1016\/S2352-3018(20)30202-2","article-title":"Spanish HIV Research Network (CoRIS). Effects of first-line antiretroviral therapy on the CD4\/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study","volume":"7","author":"S Serrano-Villar","year":"2020","journal-title":"Lancet HIV"},{"key":"pone.0260007.ref043","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jlb.56.3.335","article-title":"Molecular mechanisms of IL-4 effect on HIV expression in promonocytic cell lines and primary human monocytes","volume":"56","author":"H Naif","year":"1994","journal-title":"J Leukoc Biol"},{"key":"pone.0260007.ref044","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/infdis\/173.6.1485","article-title":"Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection","volume":"173","author":"S Sei","year":"1996","journal-title":"J Infect Dis"},{"key":"pone.0260007.ref045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1570162X15666170517130339","article-title":"The Role of IL-27 and its Receptor in the Pathogenesis of HIV\/AIDS and Anti-viral Immune Response","volume":"15","author":"YH Zheng","year":"2017","journal-title":"Curr HIV Res"},{"key":"pone.0260007.ref046","doi-asserted-by":"crossref","first-page":"101335","DOI":"10.1016\/j.smim.2019.101335","article-title":"IL-10-producing T cells and their dual functions","volume":"44","author":"T Bedke","year":"2019","journal-title":"Semin Immunol"},{"key":"pone.0260007.ref047","doi-asserted-by":"crossref","first-page":"17215","DOI":"10.1038\/s41598-018-35478-1","article-title":"HIV-1 Envelope Glycoproteins Induce the Production of TNF-\u03b1 and IL-10 in Human Monocytes by Activating Calcium Pathway","volume":"8","author":"R Plan\u00e8s","year":"2018","journal-title":"Sci Rep."},{"key":"pone.0260007.ref048","doi-asserted-by":"crossref","first-page":"101344","DOI":"10.1016\/j.smim.2019.101344","article-title":"Functions and regulation of T cell-derived interleukin-10","volume":"44","author":"C Neumann","year":"2019","journal-title":"Semin Immunol"},{"key":"pone.0260007.ref049","doi-asserted-by":"crossref","first-page":"154884","DOI":"10.1016\/j.cyto.2019.154884","article-title":"Inflammation in HIV Study Group. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV na\u00efve patients","volume":"126","author":"E Quiros-Roldan","year":"2020","journal-title":"Cytokine"},{"key":"pone.0260007.ref050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jlb.56.3.340","article-title":"IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes","volume":"56","author":"JA Mikovits","year":"1994","journal-title":"J Leukoc Biol"},{"key":"pone.0260007.ref051","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2008.0025","article-title":"Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts","volume":"21","author":"A Iannello","year":"2008","journal-title":"Viral Immunol"},{"key":"pone.0260007.ref052","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.0901967","article-title":"Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study","volume":"184","author":"A Iannello","year":"2010","journal-title":"J Immunol"},{"key":"pone.0260007.ref053","first-page":"1059","article-title":"-21 level in Chinese HIV infected individuals and its dynamics undergoing HAART","volume":"36","author":"L Zheng","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T18:30:33Z","timestamp":1637087433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260007"}},"subtitle":[],"editor":[{"given":"Cristian","family":"Apetrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260007","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}